European researchers developing organoids to spare Type 1 diabetics from lifelong insulin therapy

European researchers developing organoids to spare Type 1 diabetics from lifelong insulin therapy

by Vittorio Hernandez in International Business Times on April 04 2016 The Australian edition of the International Business Times has dedicated an article to LSFM4LIFE project on April 4, 2016, giving accurate details about the process to develop pancreatic organoids and introducing the project’s ultimate ambition to transplant three-dimensional cellular structures of insulin-producing cells into diabetes patients’ pancreas.   Related link …

MiniLSFM4LIFEteam

New EU project addresses diabetes with pancreas organoids

The innovations introduced by LSFM4LIFE strengthen the leadership of Europe in the field of advanced therapies and, in particular, in cell-based therapies. LSFM4LIFE project uses hPO as a new cell-based therapy for Type 1 Diabetes The goal of the new european project LSFM4LIFE is the production of long-term renewing pancreas organoids for the cellular therapy of type 1 diabetes. The cause of this type …